Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Boston Scientific (NY: BSX )

98.17 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. 
Via Investor's Business Daily
Stock Market Tumbles As Yields Spike; Nvidia, Tesla, Delta, Meta, Jobs Report In Focus: Weekly Review
The S&P 500 and Nasdaq are below their 50-day lines. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product
The company paused sales of a key product, a rival to Boston Scientific and Medtronic, due to safety concerns. 
Via Investor's Business Daily
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt's IVL platform addresses coronary and peripheral artery disease. 
Via Benzinga
BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why.
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP. 
Via Chartmill
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical
This was one of the few areas Boston Scientific had a gap in its coronary portfolio, an analyst says. 
Via Investor's Business Daily
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81. 
Via Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index looks at five stocks seeing increased interest from readers over the last trading week. 
Via Benzinga
S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points
Fortinet and Boston Scientific are among five stocks near buy points. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
NYSE:BSX may be ready to breakout.
Interesting Technical Analysis finding for BOSTON SCIENTIFIC CORP (NYSE:BSX) 
Via Chartmill
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
Boston Scientific updates Polarx catheter guidelines due to atrio-esophageal fistula risks, highlighting safer usage practices after FDA approval. 
Via Benzinga
Exposures Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
NYSE:BSX may be ready to breakout.
Technical Setup: BOSTON SCIENTIFIC CORP Appears Poised for a Breakout. 
Via Chartmill
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Via Benzinga
Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?
Boston Scientific's latest trial shows safety and efficacy endpoints for stroke prevention in atrial fibrillation patients. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Don’t Confuse Brains With A Bull Market, Or Price With Value
If you are interested in the stock market, maybe it is time to stop focusing on The Fed. 
Via Talk Markets
Why is Boston Scientific Stock Trading Lower On Wednesday?
Boston Scientific's ACURATE IDE trial results showed a 16.16% composite rate for mortality, stroke, or rehospitalization, not meeting non-inferiority versus controls. 
Via Benzinga
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
The major indexes were mixed for the week. 
Via Investor's Business Daily
Boston Scientific Pauses Enrollment In Farapulse Study In Drug-Naive Patients With Irregular Heart Rhythm
Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing enrollment to assess trial observations. 
Via Benzinga
Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?
Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.